Integration of multi-omics approaches in exploring intra-tumoral heterogeneity.
Uloženo v:
| Název: | Integration of multi-omics approaches in exploring intra-tumoral heterogeneity. |
|---|---|
| Autoři: | Dong, Mengmeng, Wang, Liping, Hu, Ning, Rao, Yueli, Wang, Zhen, Zhang, Yu |
| Zdroj: | Cancer Cell International; 8/29/2025, Vol. 25 Issue 1, p1-17, 17p |
| Témata: | MULTIOMICS, BIOMARKERS, PROTEOMICS, DRUG resistance, GENOMICS, CANCER invasiveness, TRANSLATIONAL research |
| Abstrakt: | Intra-tumoral heterogeneity (ITH) is common in malignant tumors and arises from dynamic variations across genetic, epigenetic, transcriptomic, proteomic, metabolic, and microenvironmental factors. This complexity drives tumor evolution and treatment resistance, undermining the accuracy of clinical diagnosis, prognosis, and treatment planning. Despite recent advances in multi-omics technologies that enable comprehensive mapping of ITH across molecular layers, major challenges remain in clinical translation. This review outlines the principles and clinical applications of eight major omics modalities in the context of ITH: genomics, single-cell genomics, transcriptomics, epigenomics, proteomics, radiomics, microbiome, and metabolomics. We highlight the unique contributions of each omics platform to tumor profiling and emphasize how their integration enhances biological interpretation, patient stratification, and biomarker discovery. Furthermore, we will focus more extensively on the limitations of applying these approaches to ITH analysis. Instead of providing an exhaustive catalog, this review highlights major controversies, technical hurdles, and conceptual gaps that impede the clinical translation of multi-omics-based ITH analysis, with the aim of addressing ITH-related clinical challenges. [ABSTRACT FROM AUTHOR] |
| Copyright of Cancer Cell International is the property of BioMed Central and its content may not be copied or emailed to multiple sites without the copyright holder's express written permission. Additionally, content may not be used with any artificial intelligence tools or machine learning technologies. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.) | |
| Databáze: | Biomedical Index |
| FullText | Text: Availability: 0 CustomLinks: – Url: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=search&db=pmc&term=1475-2867[TA]+AND+1[PG]+AND+2025[PDAT] Name: FREE - PubMed Central (ISSN based link) Category: fullText Text: Full Text Icon: https://imageserver.ebscohost.com/NetImages/iconPdf.gif MouseOverText: Check this PubMed for the article full text. – Url: https://resolver.ebscohost.com/openurl?sid=EBSCO:edm&genre=article&issn=14752867&ISBN=&volume=25&issue=1&date=20250829&spage=1&pages=1-17&title=Cancer Cell International&atitle=Integration%20of%20multi-omics%20approaches%20in%20exploring%20intra-tumoral%20heterogeneity.&aulast=Dong%2C%20Mengmeng&id=DOI:10.1186/s12935-025-03944-2 Name: Full Text Finder Category: fullText Text: Full Text Finder Icon: https://imageserver.ebscohost.com/branding/images/FTF.gif MouseOverText: Full Text Finder – Url: https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=EBSCO&SrcAuth=EBSCO&DestApp=WOS&ServiceName=TransferToWoS&DestLinkType=GeneralSearchSummary&Func=Links&author=Dong%20M Name: ISI Category: fullText Text: Nájsť tento článok vo Web of Science Icon: https://imagesrvr.epnet.com/ls/20docs.gif MouseOverText: Nájsť tento článok vo Web of Science |
|---|---|
| Header | DbId: edm DbLabel: Biomedical Index An: 187668520 RelevancyScore: 1060 AccessLevel: 6 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 1060.48706054688 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Integration of multi-omics approaches in exploring intra-tumoral heterogeneity. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AR" term="%22Dong%2C+Mengmeng%22">Dong, Mengmeng</searchLink><br /><searchLink fieldCode="AR" term="%22Wang%2C+Liping%22">Wang, Liping</searchLink><br /><searchLink fieldCode="AR" term="%22Hu%2C+Ning%22">Hu, Ning</searchLink><br /><searchLink fieldCode="AR" term="%22Rao%2C+Yueli%22">Rao, Yueli</searchLink><br /><searchLink fieldCode="AR" term="%22Wang%2C+Zhen%22">Wang, Zhen</searchLink><br /><searchLink fieldCode="AR" term="%22Zhang%2C+Yu%22">Zhang, Yu</searchLink> – Name: TitleSource Label: Source Group: Src Data: Cancer Cell International; 8/29/2025, Vol. 25 Issue 1, p1-17, 17p – Name: Subject Label: Subject Terms Group: Su Data: <searchLink fieldCode="DE" term="%22MULTIOMICS%22">MULTIOMICS</searchLink><br /><searchLink fieldCode="DE" term="%22BIOMARKERS%22">BIOMARKERS</searchLink><br /><searchLink fieldCode="DE" term="%22PROTEOMICS%22">PROTEOMICS</searchLink><br /><searchLink fieldCode="DE" term="%22DRUG+resistance%22">DRUG resistance</searchLink><br /><searchLink fieldCode="DE" term="%22GENOMICS%22">GENOMICS</searchLink><br /><searchLink fieldCode="DE" term="%22CANCER+invasiveness%22">CANCER invasiveness</searchLink><br /><searchLink fieldCode="DE" term="%22TRANSLATIONAL+research%22">TRANSLATIONAL research</searchLink> – Name: Abstract Label: Abstract Group: Ab Data: Intra-tumoral heterogeneity (ITH) is common in malignant tumors and arises from dynamic variations across genetic, epigenetic, transcriptomic, proteomic, metabolic, and microenvironmental factors. This complexity drives tumor evolution and treatment resistance, undermining the accuracy of clinical diagnosis, prognosis, and treatment planning. Despite recent advances in multi-omics technologies that enable comprehensive mapping of ITH across molecular layers, major challenges remain in clinical translation. This review outlines the principles and clinical applications of eight major omics modalities in the context of ITH: genomics, single-cell genomics, transcriptomics, epigenomics, proteomics, radiomics, microbiome, and metabolomics. We highlight the unique contributions of each omics platform to tumor profiling and emphasize how their integration enhances biological interpretation, patient stratification, and biomarker discovery. Furthermore, we will focus more extensively on the limitations of applying these approaches to ITH analysis. Instead of providing an exhaustive catalog, this review highlights major controversies, technical hurdles, and conceptual gaps that impede the clinical translation of multi-omics-based ITH analysis, with the aim of addressing ITH-related clinical challenges. [ABSTRACT FROM AUTHOR] – Name: Abstract Label: Group: Ab Data: <i>Copyright of Cancer Cell International is the property of BioMed Central and its content may not be copied or emailed to multiple sites without the copyright holder's express written permission. Additionally, content may not be used with any artificial intelligence tools or machine learning technologies. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract.</i> (Copyright applies to all Abstracts.) |
| PLink | https://erproxy.cvtisr.sk/sfx/access?url=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=edm&AN=187668520 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1186/s12935-025-03944-2 Languages: – Code: eng Text: English PhysicalDescription: Pagination: PageCount: 17 StartPage: 1 Subjects: – SubjectFull: MULTIOMICS Type: general – SubjectFull: BIOMARKERS Type: general – SubjectFull: PROTEOMICS Type: general – SubjectFull: DRUG resistance Type: general – SubjectFull: GENOMICS Type: general – SubjectFull: CANCER invasiveness Type: general – SubjectFull: TRANSLATIONAL research Type: general Titles: – TitleFull: Integration of multi-omics approaches in exploring intra-tumoral heterogeneity. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Dong, Mengmeng – PersonEntity: Name: NameFull: Wang, Liping – PersonEntity: Name: NameFull: Hu, Ning – PersonEntity: Name: NameFull: Rao, Yueli – PersonEntity: Name: NameFull: Wang, Zhen – PersonEntity: Name: NameFull: Zhang, Yu IsPartOfRelationships: – BibEntity: Dates: – D: 29 M: 08 Text: 8/29/2025 Type: published Y: 2025 Identifiers: – Type: issn-print Value: 14752867 Numbering: – Type: volume Value: 25 – Type: issue Value: 1 Titles: – TitleFull: Cancer Cell International Type: main |
| ResultId | 1 |
Full Text Finder
Nájsť tento článok vo Web of Science